Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer
- PMID: 34549319
- DOI: 10.1007/s00011-021-01501-x
Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer
Abstract
Objective: Helicobacter pylori (H. pylori) infects approximately half of the world's population, as one of the most common chronic infections. H. pylori infection has been widely recognized as a major risk factor for gastric cancer (GC).
Methods: Eradication treatment is considered to abolish the inflammatory response and prevent progression to GC. However, only 1-3% of H. pylori-infected patients develop GC, whereas GC can occur even after eradicating H. pylori. In addition, the incidence of GC following H. pylori infection is significantly higher compared to the gross incidence induced by all causes, although eradicating H. pylori reduces the risk of developing GC.
Results: Therefore, it is reasonable to hypothesize that H. pylori infection results in changes that persist even after its eradication. Several of these changes may not be reversible within a short time, including the status of inflammation, the dysfunction of immunity and apoptosis, mitochondrial changes, aging and gastric dysbacteriosis.
Conclusion: The present review article aimed to discuss these potential long-lasting changes induced by H. pylori infection that may follow the eradication of H. pylori and contribute to the development of GC.
Keywords: Aging; Apoptosis; Gastric cancer; Gastric dysbacteriosis; Helicobacter pylori; Mitochondria.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer.Gastric Cancer. 2021 May;24(3):710-720. doi: 10.1007/s10120-020-01141-w. Epub 2020 Nov 17. Gastric Cancer. 2021. PMID: 33201352 Free PMC article.
-
Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis.BMC Microbiol. 2021 Sep 23;21(1):258. doi: 10.1186/s12866-021-02315-x. BMC Microbiol. 2021. PMID: 34556055 Free PMC article. Review.
-
Characteristics of Gastric Mucosa-Associated Microbiota in Patients with Early Gastric Cancer After Successful Helicobacter pylori Eradication.Dig Dis Sci. 2023 Dec;68(12):4398-4406. doi: 10.1007/s10620-023-08154-2. Epub 2023 Oct 24. Dig Dis Sci. 2023. PMID: 37875607
-
Risk Factors for Gastric Cancer after the Eradication of Helicobacter pylori Evaluated Based on the Background Gastric Mucosa: A Propensity Score-matched Case-control Study.Intern Med. 2021 Apr 1;60(7):969-976. doi: 10.2169/internalmedicine.5486-20. Epub 2020 Nov 9. Intern Med. 2021. PMID: 33162475 Free PMC article.
-
H. pylori infection, inflammation and gastric cancer.J Gastrointest Cancer. 2014 Jun;45(2):126-32. doi: 10.1007/s12029-014-9583-1. J Gastrointest Cancer. 2014. PMID: 24557546 Review.
Cited by
-
Diversification and deleterious role of microbiome in gastric cancer.Cancer Rep (Hoboken). 2023 Nov;6(11):e1878. doi: 10.1002/cnr2.1878. Epub 2023 Aug 2. Cancer Rep (Hoboken). 2023. PMID: 37530125 Free PMC article. Review.
-
Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging.Front Immunol. 2023 Mar 31;14:1134785. doi: 10.3389/fimmu.2023.1134785. eCollection 2023. Front Immunol. 2023. PMID: 37063848 Free PMC article. Review.
-
Exploring the intricate relationship between peptic ulcers and immunohematological responses: A narrative review.Medicine (Baltimore). 2025 Apr 11;104(15):e42187. doi: 10.1097/MD.0000000000042187. Medicine (Baltimore). 2025. PMID: 40228282 Free PMC article. Review.
-
The emerging double-edged sword role of Sirtuins in the gastric inflammation-carcinoma sequence revealed by bulk and single-cell transcriptomes.Front Oncol. 2022 Oct 17;12:1004726. doi: 10.3389/fonc.2022.1004726. eCollection 2022. Front Oncol. 2022. PMID: 36324577 Free PMC article.
-
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.World J Gastrointest Oncol. 2023 Mar 15;15(3):389-404. doi: 10.4251/wjgo.v15.i3.389. World J Gastrointest Oncol. 2023. PMID: 37009320 Free PMC article. Review.
References
-
- Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, et al. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int. 2020;62(12):1315–31. https://doi.org/10.1111/ped.14388 . - DOI - PubMed - PMC
-
- Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9. https://doi.org/10.1053/j.gastro.2017.04.022 . - DOI - PubMed
-
- Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093–112. https://doi.org/10.1136/gutjnl-2020-322368 . - DOI - PubMed
-
- Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30. https://doi.org/10.1136/gutjnl-2016-312288 . - DOI - PubMed
-
- Chiang TH, Chang WJ, Chen SL, Yen AM, Fann JC, Chiu SY, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021;70(2):243–50. https://doi.org/10.1136/gutjnl-2020-322200 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous